Protocol Information

If you are interested in learning more about this study, please call or email the contact person below

Title STATIN NEUROPROTECTION AND CAROTID ENDARTERECTOMY: SAFETY, FEASIBILITY AND OUTCOMES
Description Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

Study visits will be in downtown Buffalo

If you're interested in this study, please contact the study coordinator listed below.
Objective An observational and randomized, placebo-controlled, 1,000-subject clinical trial of statin dose maximization prior to carotid endarterectomy to protect against early cognitive dysfunction

Keywords: atherosclerosis, carotid artery stenosis, neurosurgery
Principal Investigator SIDDIQUI, ADNAN
Age Group Adult
Drugs Involved
Clinical Trials.gov http://www.clinicaltrials.gov/ct2/show/NCT02850081/
Status Not Open
Key Eligibility Ages 18 and older
Currently on atorvastatin or simvastatin or rosuvastatin or statin naïve (no statins in the last 30 days)
unilateral or bilateral carotid artery stenosis that is considered severe
This stenosis has not caused any stroke, transient cerebral ischemia, or other relevant neurological symptoms in the past
Must have decided to proceed with a CEA to treat the severe carotid stenosis
Disease Group Brain/Neurological Disorders
Treatment Statin/Atorvastatin
Contact JENNIFER GAY
716-888-4811
jgay@ubns.com